Search results for "Antivirals"
HIV and chronic HBV/HCV co-infection may increase non-Hodgkin's lymphoma risk
Co-infected patients with poor immune status or restoration are at high risk for non-Hodgkin's lymphoma and death and deserve high priority for access to well-tolerated, interferon-free, direct-acting antiviral treatment programs, study authors noted.
https://immattersacp.org/weekly/archives/2016/10/18/2.htm
18 Oct 2016
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2020/04/latest-updates-on-acps-priorities-initiatives.htm
1 Apr 2020
Recent articles look at COVID-19 risk by blood type, ethical lessons, prone positioning
People in Italy and Spain with type A blood had increased risk of severe COVID-19, and prone positioning increased oxygenation, studies found. The FDA changed its position on hydroxychloroquine and ACP reaffirmed its stance.
https://immattersacp.org/weekly/archives/2020/06/23/1.htm
23 Jun 2020
HCV treatment by NPs, PCPs appears safe, effective as that provided by subspecialists
Reversing restrictions that limit prescribing of direct-acting antivirals might allow rapid escalation of safe, effective therapy for hepatitis C virus (HCV) infection and could improve the care of patients, study authors noted.
https://immattersacp.org/weekly/archives/2017/08/08/2.htm
8 Aug 2017
MKSAP Quiz: Joint pain, rash, and weakness
A 61-year-old woman is evaluated for joint pain, a rash on her legs, and weakness. She has chronic genotype 1 hepatitis C viral infection. She takes no medication. Following a physical exam and lab studies, what is the most appropriate treatment?
https://immattersacp.org/archives/2019/06/mksap-quiz-joint-pain-rash-and-weakness.htm
1 Jun 2019
Answers and even more questions on COVID-19 vaccines
In a fourth forum from ACP and Annals of Internal Medicine, infectious disease experts Carlos del Rio, MD, FACP, Paul Sax, MD, and Deborah Cotton, MD, MPH, FACP, discussed COVID-19 vaccines and their implementation, as well as other aspects of the pandemic response.
https://immattersacp.org/weekly/archives/2021/03/30/2.htm
30 Mar 2021
Experts discuss the data on post-COVID-19 symptoms
ACP and Annals of Internal Medicine's ninth COVID-19 forum addressing postacute sequelae of COVID-19 (PASC) offered a better understanding of persistent symptoms after SARS-CoV-2 infection.
https://immattersacp.org/archives/2022/07/experts-discuss-the-data-on-post-covid-19-symptoms.htm
1 Jul 2022
New COVID-19-related guidance on CPR, chest imaging, hydroxychloroquine
Medical societies addressed appropriate resuscitation and chest imaging practices for patients with COVID-19, issued guidelines on treatment and management, and warned about arrhythmia risks with hydroxychloroquine and azithromycin.
https://immattersacp.org/weekly/archives/2020/04/14/1.htm
14 Apr 2020
Latest data on COVID-19's potential treatments, effects on drug abuse and mortality
A living systematic review still only finds strong support for steroids, an antibody cocktail reduced viral load in outpatients, overdoses rose during lockdowns, and studies looked at loss of life from the pandemic.
https://immattersacp.org/weekly/archives/2020/12/22/2.htm
22 Dec 2020
MKSAP Quiz: 4 days of fever and arthralgia
A 43-year-old man is evaluated for 4 days of fever and arthralgia, as well as a raised purple rash over his lower extremities of 1 week's duration. He is a current intravenous drug user. He has no other medical problems and takes no medications. Following a physical exam, lab studies, and skin findings, what is the most appropriate treatment?
https://immattersacp.org/archives/2019/05/mksap-quiz-4-days-of-fever-and-arthralgia.htm
1 May 2019